6 results match your criteria: "University Hospital Bergmannsheil Bochum of the Ruhr-University[Affiliation]"
Subcutaneous versus Transvenous Implantable Cardioverter Defibrillator in Patients with End-Stage Renal Disease Requiring Dialysis: Extended Long-Term Retrospective Multicenter Follow-Up.
J Pers Med
August 2024
Department of Cardiology and Angiology, Marienhospital Gelsenkirchen, Academic Hospital of the Ruhr University Bochum, 45886 Gelsenkirchen, Germany.
Background: Implantable cardioverter defibrillators (ICD) prevent sudden cardiac death (SCD). Patients with end-stage renal disease (ESRD) requiring dialysis are at a very high risk of infection from cardiac implantable electronic device (CIED) implantation as well as mortality. In the present study, we compared the long-term complications and outcomes between subcutaneous ICD (S-ICD) and transvenous ICD (TV-ICD) recipients.
View Article and Find Full Text PDFComparison of infection and complication rates associated with transvenous vs. subcutaneous defibrillators in patients with stage 4 chronic kidney disease: a multicenter long-term retrospective follow-up.
Front Cardiovasc Med
April 2024
Department of Cardiology and Angiology, University Hospital Bergmannsheil Bochum of the Ruhr-University Bochum, Bochum, Germany.
Article Synopsis
- Patients with stage 4 chronic kidney disease (CKD) were studied to compare the risk of infections and complications between transvenous implantable cardioverter-defibrillators (TV-ICDs) and subcutaneously implanted ICDs (S-ICDs).
- The study included 70 patients, with follow-ups over several years, revealing that those with TV-ICDs had a higher incidence of infections, complications, and hospitalizations compared to those with S-ICDs.
- The findings suggest that S-ICDs may be a safer option for CKD patients needing prophylactic defibrillators, as they were linked to significantly fewer adverse outcomes.
Success and safety of deep sedation as a primary anaesthetic approach for transvenous lead extraction: a retrospective analysis.
Sci Rep
December 2023
Department of Cardiology and Angiology at Marienhospital Gelsenkirchen, Academic Hospital of the Ruhr University Bochum, Gelsenkirchen, Germany.
There is a rising number in complications associated with more cardiac electrical devices implanted (CIED). Infection and lead dysfunction are reasons to perform transvenous lead extraction. An ideal anaesthetic approach has not been described yet.
View Article and Find Full Text PDFLong-Term Performance Comparison of Bipolar Active vs. Quadripolar Passive Fixation Leads in Cardiac Resynchronisation Therapy.
Front Cardiovasc Med
November 2021
Department of Cardiology and Angiology at Marienhospital Gelsenkirchen, Gelsenkirchen, Germany.
Bipolar active fixation (BipolarAFL) and quadripolar passive fixation left-ventricular leads (QuadPFL) have been designed to reduce the risk of phrenic nerve stimulation (PNS), enable targeted left-ventricular pacing, and overcome problems of difficult coronary venous anatomy and lead dislodgment. This study sought to report the long-term safety and performance of a BipolarAFL, Medtronic Attain Stability 20066, compared to QuadPFL. We performed a single-operator retrospective analysis of 81 patients receiving cardiac resynchronization therapy (CRT) (36 BipolarAFL, 45 QuadPFL).
View Article and Find Full Text PDFBackground: Optimization of cardiac resynchronization therapy (CRT) is often time-consuming and therefore underused in a clinical setting. Novel device-based algorithms aiming to simplify optimization include a dynamic atrioventricular delay (AVD) algorithm (SyncAV, Abbott) and multipoint pacing (MPP, Abbott). This study examines the acute effect of SyncAV and MPP on electrical synchrony in patients with newly and chronically implanted CRT devices.
View Article and Find Full Text PDFMultipoint left ventricular pacing with large anatomical separation improves reverse remodeling and response to cardiac resynchronization therapy in responders and non-responders to conventional biventricular pacing.
Clin Res Cardiol
February 2020
Department of Cardiology and Angiology, University Hospital Bergmannsheil Bochum of the Ruhr-University, 44789, Bochum, Germany.
Background: Multipoint pacing [Multipoint™ Pacing (MPP), Abbott] via a single left ventricular lead (Quartet™ LV lead, Abbott) improves acute left ventricular (LV) function and response to cardiac resynchronization therapy (CRT). Aim of this study was to examine additional benefits in terms of LV reverse remodeling and CRT response by activating MPP in responders and non-responders to conventional biventricular pacing (CONV).
Methods: 43 consecutive patients receiving CRT (Quadra Assura MP™, Abbott) received LV dP/dt optimized CONV programming for 6 months.